United States · FDA National Drug Code directory
gadoterate meglumine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70436-123_32f1536f-eb01-305c-e063-6294a90a1855
- Product NDC
- 70436-123
- Form
- INJECTION
- Composition / generic term
- gadoterate meglumine
- Labeler
- Slate Run Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240628
- Source listing expiry
- 20261231
Source-listed ingredients
- GADOTERATE MEGLUMINE — 376.9 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (70436-123-31) / 5 mL in 1 VIAL · 70436-123-31
- 10 VIAL in 1 CARTON (70436-123-33) / 10 mL in 1 VIAL · 70436-123-33
- 10 VIAL in 1 CARTON (70436-123-34) / 15 mL in 1 VIAL · 70436-123-34
- 10 VIAL in 1 CARTON (70436-123-35) / 20 mL in 1 VIAL · 70436-123-35
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →